StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH)

StockNews.com started coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a research note released on Friday morning. The brokerage issued a hold rating on the stock.

Separately, Cantor Fitzgerald reaffirmed a neutral rating and issued a $3.30 target price on shares of Aspira Women’s Health in a research report on Wednesday, April 10th.

Aspira Women’s Health Price Performance

NASDAQ AWH opened at $3.21 on Friday. The firm’s 50-day moving average is $3.44 and its two-hundred day moving average is $3.92. Aspira Women’s Health has a 12 month low of $2.31 and a 12 month high of $6.75. The stock has a market capitalization of $39.61 million, a P/E ratio of -0.27 and a beta of 1.57.

Aspira Women’s Health (NASDAQ:AWH) last posted its earnings results on Thursday, March 28th. The company reported ($0.30) EPS for the quarter, beating analysts’ consensus estimates of ($0.39) by $0.09. Aspira Women’s Health had a negative net margin of 176.74% and a negative return on equity of 1,099.32%. The company had revenue of $2.13 million for the quarter, compared to analysts’ expectations of $2.70 million. As a group, analysts anticipate that Aspira Women’s Health will post -1.24 EPS for the current year.

Institutional Trading of Aspira Women’s Health

Several hedge funds have recently made changes to their positions in AWH. Perkins Capital Management Inc. acquired a new stake in shares of Aspira Women’s Health during the third quarter worth about $268,000. Northeast Financial Consultants Inc acquired a new stake in shares of Aspira Women’s Health during the third quarter worth about $126,000. B. Riley Wealth Advisors Inc. lifted its position in shares of Aspira Women’s Health by 39.0% during the third quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock worth $672,000 after purchasing an additional 35,177 shares in the last quarter. Finally, Quantum Private Wealth LLC lifted its position in shares of Aspira Women’s Health by 76.8% during the fourth quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock worth $205,000 after purchasing an additional 21,788 shares in the last quarter. Institutional investors and hedge funds own 12.19% of the company’s stock.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.